There are 562 opioid treatment programs (OTPs), colloquially called methadone clinics, that are owned by private equity-backed providers, according to a new analysis by STAT. The analysis also finds that this represents “nearly one-third” of all OTPs. It further contends that private interests are gaining an outside influence in the industry. It was conducted as part of a wider assessment of the years-long lobbying effort by OTP advocates to protect these facilities’ monopoly on the distribution of methadone for treating opioid use disorder (OUD). The OTP space has primarily been a for-profit endeavor for years. It has increasingly been so in the last decade.
Read the full article: Nearly One-Third of OTPs Are Owned by Private Equity Firms //
Source: https://bhbusiness.com/2024/03/19/nearly-one-third-of-otps-are-owned-by-private-equity-firms